RATIONAL DESIGN OF ANTISICKLING AGENTS
RATIONAL DESIGN OF ANTISICKLING AGENTS
批准号:
6526574
负责人:
Martin K Safo
金额:
$9.02万
依托单位国家:
美国
项目类别:
财政年份:
2000
资助国家:
美国
项目状态:
已结题
起止时间:
2000-09-01 至 2005-08-31
关键词:
X ray crystallography allosteric site aromatic hydrocarbon receptor chemical binding chemical structure function computer simulation drug design /synthesis /production drug screening /evaluation halogenation halogens hemoglobin human tissue hydrocarbons organic chemicals respiratory gas analyzer sickle cell anemia sickling inhibitor spectrometry stereochemistry temperature jump
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (Adapted from applicant's abstract) The applicant's career goal
is to seek a research position in a reputable Institution. His primary goal would be
to establish rigorous research programs involving structure-based drug design to
find the origin, causes, treatment and prevention of tropical diseases, such
as sickle cell anemia, malaria, and sleeping sickness. Furthermore, it is
anticipated that molecular modeling techniques unique to the problems to be
encountered will be developed to improve the efficiency of the drug
development process. To reach these goals, would require considerable
experience and skills in drug designing process. Therefore, under the
direction of his mentor, he intends to initiate a career development research
program involving rational development of compounds to treat sickle cell
anemia. This would help him gain the necessary skills and experience to
develop his career as an independent researcher. Below is a brief description
of the proposal research.
A group of halogenated aromatic compounds are known to bind to hemoglobin and
show potential as antisickling agents. These compounds bind to the surface of
the protein and may explain the antisickling properties. The long term-goal
of this research project is to utilize the above information to design and
develop stereospecific agents to bind with high affinity to the surface of the
hemoglobin for more potent antisickling agents. In addition, both the T and
R-state hemoglobins will be used to study structure-function activities.
Therefore, the specific aims are: 1) determine and refine the crystal
structures of the deoxygenated hemoglobin co-crystallized with halogenated
aromatic acids; 2) determine and refine the crystal structures of carbonmonoxy
hemoglobin bound with halogenated aromatic acid; 3) rational design of new
stereospecific compounds to bind to known binding sites at the surface of the
hemoglobin, and other newly identified binding sites; and 4) biological
evaluation of the designed compounds for antisickling, antigelling and
allosteric activities.
期刊论文(3)
专著(0)
科研奖励(0)
会议论文
Structures of R- and T-state hemoglobin Bassett: elucidating the structural basis for the low oxygen affinity of a mutant hemoglobin.
R 态和 T 态血红蛋白的结构 Bassett:阐明突变血红蛋白的低氧亲和力的结构基础。
DOI:
10.1107/s0907444904030501
发表时间:
2005
期刊:
Acta crystallographica. Section D, Biological crystallography
影响因子:
--
作者:
[Safo,MartinK, Abdulmalik,Osheiza, Lin,HsiangRu, Asakura,Toshio, Abraham,DonaldJ]
通讯作者:
Abraham,DonaldJ
Structure of cytomegalovirus nuclease, UL98
-
批准号:8969474
-
项目类别:
-
资助金额:$7.63万
-
财政年份:2015
-
负责人:Martin K Safo
-
依托单位:
Structure of cytomegalovirus nuclease, UL98
-
批准号:9086246
-
项目类别:
-
资助金额:$7.63万
-
财政年份:2015
-
负责人:Martin K Safo
-
依托单位:
Hemoglobin Modifiers for Sickle Cell Disease Therapy
-
批准号:8776137
-
项目类别:
-
资助金额:$40.9万
-
财政年份:2014
-
负责人:Martin K Safo
-
依托单位:
Hemoglobin Modifiers for Sickle Cell Disease Therapy
-
批准号:9250636
-
项目类别:
-
资助金额:$39.59万
-
财政年份:2014
-
负责人:Martin K Safo
-
依托单位:
Hemoglobin Modifiers for Sickle Cell Disease Therapy
-
批准号:9053281
-
项目类别:
-
资助金额:$39.59万
-
财政年份:2014
-
负责人:Martin K Safo
-
依托单位:
Hemoglobin Modifiers for Sickle Cell Disease Therapy
-
批准号:9445715
-
项目类别:
-
资助金额:$2.55万
-
财政年份:2014
-
负责人:Martin K Safo
-
依托单位:
Hemoglobin Modifiers for Sickle Cell Disease Therapy
-
批准号:9147091
-
项目类别:
-
资助金额:$5.32万
-
财政年份:2014
-
负责人:Martin K Safo
-
依托单位:
Structure of Beta-lactam resistance regulators
-
批准号:7229829
-
项目类别:
-
资助金额:$21.7万
-
财政年份:2006
-
负责人:Martin K Safo
-
依托单位:
Structure of Beta-lactam resistance regulators
-
批准号:7014710
-
项目类别:
-
资助金额:$18.63万
-
财政年份:2006
-
负责人:Martin K Safo
-
依托单位:
Rational Design of Novel Estrogen Receptor Antagonists
-
批准号:7174671
-
项目类别:
-
资助金额:$29.16万
-
财政年份:2004
-
负责人:Martin K Safo
-
依托单位:
RATIONAL DESIGN OF ANTISICKLING AGENTS
-
批准号:6388665
-
项目类别:
-
资助金额:$8.85万
-
财政年份:2000
-
负责人:Martin K Safo
-
依托单位:
RATIONAL DESIGN OF ANTISICKLING AGENTS
-
批准号:6143995
-
项目类别:
-
资助金额:$8.96万
-
财政年份:2000
-
负责人:Martin K Safo
-
依托单位:
海外基金